Intravenous regional block is similar to sympathetic ganglion block for pain management in patients with complex regional pain syndrome type I

Nascimento, Maria Salete A.; Klamt, Jyrson Guilherme; Prado, Wiliam A.

doi:10.1590/s0100-879x2010007500123

Cited by 19 publications

(9 citation statements)

References 36 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…All groups had a significant decrease in pain, but there were no significant differences between groups. 18 There are two critical points in this study: first, the amount of lidocaine used in the injections is higher than usual, which has contributed to immediate pain relief in patients who underwent SGB. Second, a fourth injection was applied to the patients, but this additional injection does not seem to improve pain scores.…”

Section: Introductionmentioning

confidence: 99%

Ganglion blocks as a treatment of pain: current perspectives

Gündüz

Keniş-Coşkun

2017

JPR

105

View full text Add to dashboard Cite

The inputs from sympathetic ganglia have been known to be involved in the pathophysiology of various painful conditions such as complex regional pain syndrome, cancer pain of different origin, and coccygodynia. Sympathetic ganglia blocks are used to relieve patients who suffer from these conditions for over a century. Many numbers of local anesthetics such as bupivacaine or neurolytic agents such as alcohol can be chosen for a successful block. The agent is selected according to its duration of effect and the purpose of the injection. Most commonly used sympathetic blocks are stellate ganglion block, lumbar sympathetic block, celiac plexus block, superior hypogastric block, and ganglion Impar block. In this review, indications, methods, effectiveness, and complications of these blocks are discussed based on the data from the current literature.

show abstract

Section: Introductionmentioning

confidence: 99%

Ganglion blocks as a treatment of pain: current perspectives

Gündüz

Keniş-Coşkun

2017

JPR

105

View full text Add to dashboard Cite

show abstract

“…For instance, only one clearly described the randomization process [52] and only 2 were double-blinded [3,43]. In 5 studies, the blinding procedure was unclear [7,37,45,52,56], and one was not blinded at all [47]. The number of patients included in these trials ranged from 4 to 82 [43,47].…”

Section: Discussionmentioning

confidence: 99%

“…The timing of assessment also was quite variable, ranging from right after the blocking procedure [43] to 3 months post treatment [47]. Some studies (n = 6) used control blocks with active drugs such as guanethidine [7], lidocaine with clonidine [37], phentolamine [45,56], or continuous infraclavicular brachial plexus block [52]. In one study, physical therapy was added to the baseline treatment [47].…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Thoracic sympathetic block for the treatment of complex regional pain syndrome type I: A double-blind randomized controlled study

Rocha

Teixeira

Yeng

et al. 2014

Pain

View full text Add to dashboard Cite

Pain relief in complex regional pain syndrome (CRPS) remains a major challenge, in part due to the lack of evidence-based treatment trials specific for this condition. We performed a long-term randomized, double-blinded active-control study to evaluate the efficacy of thoracic sympathetic block (TSB) for upper limb type I CRPS. The study objective was to evaluate the analgesic effect of TSB in CRPS. Patients with CRPS type I were treated with standardized pharmacological and physical therapy and were randomized to either TSB or control procedure as an add-on treatment. Clinical data, pain intensity, and interference (Brief Pain Inventory), pain dimensions (McGill Pain Questionnaire [MPQ]), neuropathic characteristics (Neuropathic Pain Symptom Inventory [NPSI]), mood, upper limb function (Disabilities of Arm, Shoulder and Hand), and quality of life were assessed before, and at 1 month and 12 months after the procedure. Thirty-six patients (19 female, 44.7 ± 11.1 years of age) underwent the procedure (17 in the TSB group). Average pain intensity at 1 month was not significantly different after TSB (3.5 ± 3.2) compared to control procedure (4.8 ± 2.7; P=0.249). At 12 months, however, the average pain item was significantly lower in the TSB group (3.47 ± 3.5) compared to the control group (5.86 ± 2.9; P=0.046). Scores from the MPQ, evoked-pain symptoms subscores (NPSI), and depression scores (Hospital Anxiety and Depression Scale) were significantly lower in the TSB group compared to the control group at 1 and at 12 months. Other measurements were not influenced by the treatment. Quality of life was only slightly improved by TSB. No major adverse events occurred. Larger, multicentric trials should be performed to confirm these original findings.

show abstract

“…4 The use of regional intravenous lidocaine has been well-documented in the literature with a successful decrease in pain symptoms. [5][6][7] This procedure is performed by applying a tourniquet and then infusing lidocaine into the affected limb. Below, we present a unique patient case detailing the use of systemic intravenous lidocaine, which has been far less documented in the literature.…”

Section: Introductionmentioning

confidence: 99%

Systemic Intravenous Lidocaine for the Treatment of Complex Regional Pain Syndrome: A Case Report and Literature Review

Rickard

Kish

2016

American Journal of Therapeutics

View full text Add to dashboard Cite

Complex regional pain syndrome (CRPS) was described in 1864 by Mitchell et al as a condition characterized by many unique symptoms. Although symptoms may differ from patient to patient, the most common complaints are painful swelling in upper or lower extremities or changes in the skin. CRPS has been given many different names since it was first mentioned in the literature in 1851. The most common alternative names include causalgia, aglodystrophy, and sympathetic dystrophy syndrome. This condition is generally diagnosed in older adults because of trauma, nerve damage, and coronary artery disease; however, there are cases of CRPS affecting the pediatric and young adult population. The fourth edition of the diagnostic and treatment guidelines of CRPS published by Harden et al in 2013 suggest many different pharmacologic treatment options for these patients. Intravenous lidocaine is used to block the sodium channels in neuronal membranes, thus stopping initiation and conduction of impulses associated with neuropathic and inflammatory pain. The use of regional intravenous lidocaine (by applying a tourniquet on the affected extremity) has been well-documented in the literature with a successful decrease in pain symptoms. A unique case of the use of systemic intravenous lidocaine will be presented.

show abstract

Intravenous regional block is similar to sympathetic ganglion block for pain management in patients with complex regional pain syndrome type I

Cited by 19 publications

References 36 publications

Ganglion blocks as a treatment of pain: current perspectives

Ganglion blocks as a treatment of pain: current perspectives

Thoracic sympathetic block for the treatment of complex regional pain syndrome type I: A double-blind randomized controlled study

Systemic Intravenous Lidocaine for the Treatment of Complex Regional Pain Syndrome: A Case Report and Literature Review

Contact Info

Product

Resources

About